persistent ductus arteriosus (PDA). Our purpose is now to evaluate, if percutaneous PDA closure using a coil catheter delivery system is also associated to equal morbidity.
Introduction: African-American hypertensives (AA) respond poorly to angiotensin converting enzyme inhibitors (ACEI) and angiotensin receptors blockers (ARB) individually. This study investigates the effect of ACEI and ARBs individually and in combination, on diastolic blood pressure (DBP), plasma renin activity (PRA) and angiotensin II levels, in these patients.
Methods: After baseline evaluation 44 AA patients, age 61.2Ϯ9.6 yrs, were randomized to ACEI enalapril (E) 10 mg (E4), increased to 20 mg (E8) after 4wks, or ARB candesartan (C) 16 mg (C4) increased to 32 mg (C8) after 4wks. After a total of 8wks of therapy, patients were crossed over to the other arm. Patients not responding to either of the two drugs were treated with a combination of both, starting with enalapril 10mg ϩcandesartan 16 mg (CE4) for 4wks and then enalapril 20 mgϩ candesartan 32mg (CE8) for 4 wks. At the end of each phase complete clinical and laboratory evaluation including chemistry, PRA AII levels, was done.
Results: At 4 8 wks DBP was significantly reduced with both E C. Non-responers (nϭ17) who received combination therapy with both E ϩ C, showed only minimal additional fall in DBP. PRA increased only with C and CE at 4 8 wks. AII levels increased only with high dose E.
Conclusion: All treatments decreased DBP significantlly but the magnitude of change was small. The relatively poor response of BP to ACEI and ARBs in AA may be related to inadequate blockade of angiotensin converting enzyme or AT 1 receptor or rapid return of ATII level to baseline. Combination of ARB and ACEI did improve the response significantly. Salt sensitive hypertensives (SSHT) differently from salt-resistants -SR are prone to exhibit a blunted nocturnal BP fall when switching from low to high salt intake. In 10 black SSHTs (ageing 35-64 yrs, 5 male) and in 10 black SRs (ageing 32-60 yrs, 4 male) we examined separately during daytime (6.00-22.00 h) and nighttime (22.00-6.00h), the BP (Spacelabs 90207), the aldosterone activity by measuring plasmatic aldosterone to renin ratio (ARR), and the plasma and urinary sodium, potassium and creatinine values, on the last day of 2x2 weeks on high-sodium diet (HS, 300 mmol Naϩ/d) and on low salt diet (LS, 20 mmol Naϩ/d-2 weeks) and after an acute salt load while on LS diet (LS-infusion) (i. of 2L NaCl both during daytime and nighttime). On LS, HS and LSinfusion, nighttime/daytime MAP fall (%) were in HTSS of 9.4(1.1) on LS-pl; 3.4(0.9) on HS-pl; and 2.4(1.0) on LS-infusion (pϽ0.03, LS v HS LS-infusion) and in SR of of 9.2(1.2) on LS-pl; 7.4(1.3) on HS-pl; and 6.8(1.2) on LS-infusion (n.s.). On HS, ARR was 1.8 times greater in SSHT v SR and it was attenuated from daytime to nighttime by 25.6 (6.3)% (pϽ0.02) in SRs subjects but only by 5.1 (1.1)% (n.s.) in SSHT; saline infusion on LS reduced ARR during nighttime by 37.4 (7.4) % (pϽ0.02) in SR subjects but only by 1.1 (1.9) % (n.s) in SSHTs. Also on LS, saline infusion similarly increased sodium excretion in both SR and SSHT but it decreased serum potassium and reduced urinary potassium excretion (from daytime to nighttime) in SR whereas the opposite occurred in HTSS. We conclude that differently from SR, SSHT while submitted to chronic or acute sodium loading show greater BP levels during nighttime which may be related with a nocturnal inappropriate increase of aldosterone activity and with a reduced potassium balance.
Key Words: Salt sensitive hypertension, Renin angiotensin system, Mechanisms We have recently reported evidence to indicate that AngII-dependent renal vascular tone differs in healthy blacks and whites. There is evidence for AngII generation via pathways that do not involve ACE in humans.
P-357 NON-ACE PATHWAY IN RENAL ANGII GENERATION:ARE THERE ETHNIC DIFFERENCES?
In view of the risk of nephropathy in blacks and the role that AngII plays in the evolution of nephropathy, we undertook to explore the detailed mechanisms more fully in 13 healthy blacks (40Ϯ4yrs) and 11 healthy whites (45Ϯ6yrs). While in low salt balance (10 mmol Na ϩ /day), renal plasma flow response (PAH clearance) was measured in subjects who randomly received 25 mg captopril and 16 mg candesartan on separate days. The groups had both similar baseline RPF on the captopril day (549Ϯ26 vs 561Ϯ28 ml/mim/1.73m 2 ; blacks vs whites) and comparable increases with captopril 610Ϯ29(pϭ0.0009) vs 628Ϯ44 ml/min/ 1.73m 2 (pϭ0.0069); blacks vs whites. On the candesartan day, baseline RPF was again comparable (568Ϯ23 vs 556Ϯ27 ml/min/1.73m 2 ; black vs white) and again RPF rose comparably in the blacks and whites, 667Ϯ22 (pϽ0.0001) vs 667Ϯ43 ml/min/1.73m 2 (pϭ0.0009); blacks vs whites. The change in the RPF response from baseline with captopril in blacks was 60Ϯ12 ml/min/1.73m 2 compared to 99Ϯ14 ml/min/1.73m 2 with candesartan (pϭ0.0598). For whites the response was 67Ϯ20 ml/ min/1.73m 2 with captopril and 111Ϯ24 ml/min/1.73m 2 with candesartan (pϭ0.008).
The renal vascular response to candesartan was about 40-50% larger than the renal vascular response to captopril. Thus, a significant non-ACE pathway for AngII generation exists in both groups and does not appear to differ quantitatively in blacks.
Key Words: race, kidney, non-ACE pathway José R Romero, Ana Ferreira, Alicia Rivera, Radomir Stevanovic, Deborah A Price, Naomi DL Fisher. Div. of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Depts. of Pathology and Laboratory Medicine, Children's Hospital, Harvard Medical School, Boston, MA. African Americans have been shown to exhibit lower urinary potassium excretion when compared to Caucasians. Angiotensin II regulates both potassium handling by the kidney and the Na-K-2Cl (NKCC) cotransporter in vitro . However, little is known about the role of the reninangiotensin system (RAS) in human NKCC cotransport regulation in vivo. We hypothesized that regulation of RAS would induce concomitant alterations in NKCC activity in humans. The kidney and erythrocyte express NKCC-1 isoform. Therefore, we measured NKCC-1 activity in freshly isolated ex vivo red cells from 12 healthy blacks and 11 healthy whites in high (200 mmol/d) and low (10 mmol/d) salt balance, followed by a measure 24 h-post candesartan [16 mg] to block angiotensin II type I receptors on low salt diet. Baseline NKCC cotransport activity was significantly lower in Blacks when compared to Whites in balance on a typical high salt diet, and was reduced when the subjects were placed on a low salt diet in whites only. Administration of candesartan reversed the reduction seen with low salt diet in whites, where as in blacks there was no significant effect. These data suggest altered in vivo regulation of NKCC-1 via RAS in Blacks when compared to Whites, and provide a mechanism that may in part explain the altered potassium handling observed among otherwise healthy African Americans.
P-358 RENIN-ANGIOTENSIN SYSTEM ALTERS NKCC-1 COTRANSPORT ACTIVITY IN HEALTHY WHITE BUT NOT BLACK SUBJECTS

